The global conjugation and labeling services market, valued at USD 1,088 million in 2025, is projected to reach USD 1,195 million in 2026 and USD 2,902 million by 2035, with a 10.4% CAGR during the forecast period 2026 to 2035. The current market landscape features the presence of over 170 companies providing antibody conjugation services and 120 companies providing service for protein labeling, spread across the globe. Further, it is worth highlighting that, since 2018, over 70 strategic partne...

The global bispecific antibodies market, valued at USD 8.93 billion in 2025, is projected to reach USD 8.78 billion in 2026 and USD 16.81 billion by 2035, with a 7.5% CAGR during the forecast period 2026 to 2035. Bispecific antibodies (BsAbs) represent a novel class of antibodies that act by simultaneously attaching to two separate / distinct antigens or different epitopes of the same antigen. It is worth mentioning that, till date, 15 bispecific antibodies have been approved for therapeutic use...

The global fermenters and bioreactors market is estimated to grow from USD 25.9 billion in 2025 to reach USD 29.1 billion in 2026 and USD 73.7 billion by 2035, representing a higher CAGR of 10.9% during the forecast period. In fact, in the past two decades, over 170 biopharmaceuticals have already been granted approval by the FDA and over 7,500 biological interventions are under evaluation in clinical trials. It is a well-known fact that the commercial and clinical scale manufacturing of such co...

The single use bioprocessing market, valued at USD 5.1 billion in 2025, is projected to grow to USD 5.8 billion in 2026 and USD 15.5 billion by 2035, representing a CAGR of 11.5% during the forecast period. Several single-use bioprocessing companies are engaged in developing and manufacturing single-use upstream bioprocessing technologies and equipment, such as single use bioreactors, single use mixers, single-use filters, single-use media bags and containers, single-use sampling systems and sin...

As per recent studies, the annual burden of oncological disorders is more than USD 185 billion in the US. In order to address the aforementioned challenge, various developers across the globe, have identified inhibition of enhancer of zeste homolog 2 (EZH2) as one of the potential target mechanisms. Over the years, inhibition of the EZH2 gene has been validated across various studies to suppress the growth of cancer cells. Notably, the first EZH2 inhibitor, Tazemetostat was approved by the USFDA...

The global cell therapy media market, valued at USD 1.6 billion in 2025, is projected to reach USD 1.8 billion in 2026 and USD 4.5 billion by 2035, with a 10.6% CAGR during the forecast period 2026 to 2035. The cell therapy consumable providers market landscape features more than 80 companies, which claim to possess the necessary expertise for manufacturing of over 450 research and / or therapeutic grade raw materials. Further, it is worth highlighting that more than USD 35 billion has already i...

Orthokeratology is defined as the use of custom designed (as per the patient

The global DNA encoded library market is estimated to grow from USD 1.2 billion in 2025 to reach USD 1.3 billion in 2026 and USD 5.0 billion by 2035, representing a higher CAGR of 16.3% during the forecast period 2026 to 2035. The growing adoption of DNA encoded chemical libraries by pharmaceutical and biotechnology companies, academic institutions and contract research organizations has further propelled the market growth of this industry. Driven by the ongoing pace of innovation in this field...

The global viral clearance market valued at USD 615 million in 2025, is project to reach USD 664 million in 2026 and USD 1,704 million by 2035, representing a higher CAGR of 11.0% during the forecast period 2026 to 2035. In terms of scale of operation, the clinical segment holds the highest share (more than 85%) of the market. With regards to method of viral clearance and testing, the viral removal segment dominates the global market with 55% market share. Based on the end users, the contract re...

According to the National Health Council, nearly 40% of the adult population in the US is diagnosed with at least one chronic condition, such as diabetes, asthma, and hypertension. The annual cost burden associated with chronic diseases in the US is around USD 3.8 trillion. This has prompted stakeholders to develop devices that enable self-administration of drugs. Amongst the various self-injection devices, autoinjectors have steadily gained prominence, especially for the treatment of emergency...

Tissue injury and dysfunctioning commonly occurs in humans; however, not in all cases, the tissue regeneration capability of a human body is able to cope up with the damage caused. o improve on this aspect, additive manufacturing, specifically 3D bioprinting, is being explored in the tissue engineering domain. The 3D bioprinting technique employs bioinks (consisting of living cells and biomaterials) to fabricate complex anatomical structures (tissues, cartilages and organs), in a layer-by-layer...

The global monkeypox treatment market size is estimated to shrink from USD 86 million in 2026 to USD 4.8 million by 2035, representing a CAGR of (-)27.4% during the forecast period 2026 to 2035. In May 2022, multiple cases of the disease were reported in several non-endemic countries, thereby making monkeypox a disease of global concern. In fact, till date, over 71,000 cases of the disease have been reported, globally. In response to the monkeypox outbreak, active research and development effort...

The global blockchain in healthcare market valued at USD 78 million in 2025, is project to reach USD 96 million in 2026 and USD 641 million by 2035, representing a higher CAGR of 23.5% during the forecast period 2026 to 2035. In terms of type of blockchain, the private blockchain segment holds the highest share (~40%) of the market. With regards to type of end-user, the hospitals segment dominates the global market with 35% market share. In terms of geographical regions, Asia-Pacific captures th...

The 4D bioprinting market, valued at USD 31 million in 2025, is projected to grow to USD 40 million in 2026 and USD 684 million by 2035, representing a CAGR of 37.2% during the forecast period. Owing to the ongoing advancements in the 4D bio fabrication technology, several players are actively adopting and developing 4D bioprinters and smart biomaterials. It is worth highlighting that 4D bioprinting is garnering a lot of attention from academicians and industry players. In fact, the volume of af...

The global exosome therapy market is estimated to grow from USD 32 million in 2029 to reach USD 382 million in 2035 and USD 1,405 million by 2040, representing a higher CAGR of 41.1% during the forecast period. In recent years, therapies utilizing extracellular vesicles have garnered significant attention among the industry stakeholders for the treatment of diverse indications, primarily owing to the various benefits offered by them, including target specificity, enhanced tissue regeneration, an...

Attempts to synthetically recreate the biological circuits in human body is a relatively new area of research within synthetic biology. Ever since the 2010s, the use of molecular

The at home testing kits market, valued at USD 18.21 billion in 2025, is projected to grow to USD 19.24 billion in 2026 and USD 31.15 billion by 2035, representing a CAGR of 5.5% during the forecast period. Since the approval of the first over-the-counter test kits in early 1976, there has been a substantial increase in the development initiatives focused on such products. In this context, it is worth highlighting that over 20 million at-home pregnancy test kits are being annually sold in the US...

The global handheld ultrasound scanners market is estimated to grow from USD 583 million in 2024 to USD 1,142 million by 2030, representing a CAGR of 12% during the forecast period. Point-of-care ultrasound or handheld ultrasound imaging devices emerged as a viable solution to empower clinicians with portable, mobile, and lightweight scanners for disease diagnosis. For instance, Butterfly IQ (an innovative handheld ultrasound scanner) is available at only 2% of the cost of a conventional ultraso...

The drug device combination products market, valued at USD 327 million in 2025, is projected to grow to USD 357 million in 2026 and USD 938 million by 2035, representing a CAGR of 11.3% during the forecast period. Combination products comprise of two or more FDA- regulated components that provide controlled release of the APIs. However, the development of drug-device combination products is a long-drawn-out process that not only requires novel technologies and processes but also a huge amount of...

Over the last 2 decades, gene editing concepts and genetic engineering have evolved significantly, with the development of a variety of versatile DNA modulation technologies, including clustered, regularly interspaced short palindromic repeats (CRISPR), zinc finger nucleases and transcription activator-like effector-based nucleases (TALENs). CRISPR / Cas system is a powerful tool with a wide array of applications in the field of disease treatment and diagnosis, and agriculture and biotechnology....